ADHD isn't diagnosed equally.

A large body of research documents racial, ethnic, and socioeconomic disparities in who gets diagnosed and treated for ADHD. Historically, when symptoms are comparable, children from minority groups have been less likely to be diagnosed — and less likely to receive medication, school accommodations, or support. A US national birth-cohort study found Asian, Black and Hispanic children significantly less likely than White children to be diagnosed with ADHD, and less likely to receive treatment.

One honest caveat: the picture is genuinely mixed. But a JAMA Psychiatry meta-analysis found Black individuals at higher risk of ADHD diagnosis than the general population, explicitly challenging the assumption of lower prevalence — so findings genuinely diverge by dataset, era and age group. What's consistent is the inequity — in the timing of diagnosis, in access to treatment, and in how the same behaviour gets interpreted.

A key mechanism is misattribution: in minority children, the same inattention or restlessness is more likely to be labelled a conduct or oppositional problem — defiance — rather than ADHD. One large 2024 analysis of over 800,000 records found White individuals about 26% more likely to receive an ADHD diagnosis and around 61% less likely to receive a conduct-disorder diagnosis than Black individuals, with the average age of ADHD diagnosis more than eight years older for White patients. Barriers stack up behind this: gaps in provider and caregiver knowledge, cultural stigma around mental health, cost and access, and language. And it compounds with gender — Black girls are among the least likely to be identified at all.